# An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis

> **NCT00601484** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 65 (actual)

## Conditions studied

- Cystitis, Interstitial

## Interventions

- **DRUG:** PF-04383119
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00601484
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03-17
- **Primary completion:** 2009-04-15
- **Final completion:** 2009-04-15
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2021-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00601484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00601484, "An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00601484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*